UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial Participation

JNCI : Journal of the National Cancer Institute, 2019-03, Vol.111 (3), p.245-255

2019

Volltextzugriff (PDF)

The Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies

American Society of Clinical Oncology educational book, 2016, Vol.36 (36), p.185-198

2016

Volltextzugriff (PDF)

The COVID-19 pandemic and new clinical trial activations

Trials, 2021-04, Vol.22 (1), p.260-260, Article 260

2021

Volltextzugriff (PDF)

Association between Body Mass Index and Cancer Survival in a Pooled Analysis of 22 Clinical Trials

Cancer epidemiology, biomarkers & prevention, 2017-01, Vol.26 (1), p.21-29

2017

Volltextzugriff (PDF)

Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical Trials

Journal of clinical oncology, 2022-05, Vol.40 (13), p.1474-1486

2022

Volltextzugriff (PDF)

Patient Income Level and Cancer Clinical Trial Participation

Journal of clinical oncology, 2013-02, Vol.31 (5), p.536-542

2013

Volltextzugriff (PDF)

Comparison of Survival Outcomes Among Cancer Patients Treated In and Out of Clinical Trials

JNCI : Journal of the National Cancer Institute, 2014-03, Vol.106 (3), p.dju002-dju002

2014

Volltextzugriff (PDF)

Geographic social inequalities in information-seeking response to the COVID-19 pandemic in China: longitudinal analysis of Baidu Index

Scientific reports, 2022-07, Vol.12 (1), p.12243-12243, Article 12243

2022

Volltextzugriff (PDF)

Publisher Correction: Geographic social inequalities in information-seeking response to the COVID-19 pandemic in China: longitudinal analysis of Baidu Index

Scientific reports, 2022-07, Vol.12 (1), p.12927-12927, Article 12927

2022

Volltextzugriff (PDF)

Randomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor-Associated Arthralgias in Early-Stage Breast Cancer: SWOG S1202

Journal of clinical oncology, 2018-02, Vol.36 (4), p.326-332

2018

Volltextzugriff (PDF)

Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy

Journal of clinical oncology, 2013-07, Vol.31 (20), p.2627-2633

2013

Volltextzugriff (PDF)

Automatic electronic reporting improved the completeness of AMI and stroke incident surveillance in Tianjin, China: a modeling study

Population health metrics, 2023-02, Vol.21 (1), p.2-2, Article 2

2023

Volltextzugriff (PDF)

Dynamic zero-COVID policy and healthcare utilization patterns in China during the Shanghai COVID-19 Omicron outbreak

Communications medicine, 2023-10, Vol.3 (1), p.143-143, Article 143

2023

Volltextzugriff (PDF)

Impact of the Pilot Volume-Based Drug Purchasing Policy in China: Interrupted Time-Series Analysis with Controls

Frontiers in pharmacology, 2021-12, Vol.12, p.804237-804237

2021

Volltextzugriff (PDF)

Population, Clinical, and Scientific Impact of National Cancer Institute's National Clinical Trials Network Treatment Studies

Journal of clinical oncology, 2023-04, Vol.41 (11), p.2020-2028

2023

Volltextzugriff (PDF)

Phase II Study of Rituximab Plus Three Cycles of CHOP and Involved-Field Radiotherapy for Patients With Limited-Stage Aggressive B-Cell Lymphoma: Southwest Oncology Group Study 0014

Journal of clinical oncology, 2008-05, Vol.26 (14), p.2258-2263

2008

Volltextzugriff (PDF)

Natural History of CNS Relapse in Patients With Aggressive Non-Hodgkin's Lymphoma: A 20-Year Follow-Up Analysis of SWOG 8516—The Southwest Oncology Group

Journal of clinical oncology, 2009-01, Vol.27 (1), p.114-119

2009

Volltextzugriff (PDF)

New Treatment Options Have Changed the Survival of Patients With Follicular Lymphoma

Journal of clinical oncology, 2005-11, Vol.23 (33), p.8447-8452

2005

Volltextzugriff (PDF)

Sex, Racial, and Ethnic Representation in COVID-19 Clinical Trials: A Systematic Review and Meta-analysis

JAMA internal medicine, 2023-01, Vol.183 (1), p.50

2023

Volltextzugriff (PDF)

Phase II Trial of CHOP Chemotherapy Followed by Tositumomab/Iodine I-131 Tositumomab for Previously Untreated Follicular Non-Hodgkin's Lymphoma: Five-Year Follow-Up of Southwest Oncology Group Protocol S9911

Journal of clinical oncology, 2006-09, Vol.24 (25), p.4143-4149

2006

Volltextzugriff (PDF)

Racial and Ethnic Disparity in Preference-Weighted Quality of Life: Findings from the Selenium and Vitamin E Cancer Prevention Trial

Population health management, 2023-01

2023

Volltextzugriff (PDF)

Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials

The New England journal of medicine, 1999-12, Vol.341 (27), p.2061-2067

1999

Volltextzugriff (PDF)

Lost in Translation: Participation in Cancer Clinical Trials for Patients With Limited English Proficiency

Journal of the National Comprehensive Cancer Network, 2023-01, Vol.21 (1), p.99-100

Unger, Joseph M

2023

Volltextzugriff (PDF)

A comparison of nurses' and physicians' perception of cancer treatment burden based on reported adverse events

Health and quality of life outcomes, 2019-08, Vol.17 (1), p.146-146, Article 146

2019

Volltextzugriff (PDF)

“When Offered to Participate”: A Systematic Review and Meta-Analysis of Patient Agreement to Participate in Cancer Clinical Trials

JNCI : Journal of the National Cancer Institute, 2021-03, Vol.113 (3), p.244-257

2021

Volltextzugriff (PDF)

1 – 25 von 413

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(400)
Mit Volltextzugriff
(341)

Publikationsform

Sprache

Englisch
(412)
Deutsch
(1)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(104)
Cancer
(22)
Blood
(21)
Jnci : Journal Of The National Cancer Institute
(18)
Jama Oncology
(17)
Journal Of The National Cancer Institute
(16)
Jama Network Open
(15)
Jco Oncology Practice
(13)
Cancer Research
(8)
American Journal Of Veterinary Research
(6)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(7)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial Participation

The Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies

The COVID-19 pandemic and new clinical trial activations

Association between Body Mass Index and Cancer Survival in a Pooled Analysis of 22 Clinical Trials

Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical Trials

Patient Income Level and Cancer Clinical Trial Participation

Comparison of Survival Outcomes Among Cancer Patients Treated In and Out of Clinical Trials

Geographic social inequalities in information-seeking response to the COVID-19 pandemic in China: longitudinal analysis of Baidu Index

Publisher Correction: Geographic social inequalities in information-seeking response to the COVID-19 pandemic in China: longitudinal analysis of Baidu Index

Randomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor-Associated Arthralgias in Early-Stage Breast Cancer: SWOG S1202

Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy

Automatic electronic reporting improved the completeness of AMI and stroke incident surveillance in Tianjin, China: a modeling study

Dynamic zero-COVID policy and healthcare utilization patterns in China during the Shanghai COVID-19 Omicron outbreak

Impact of the Pilot Volume-Based Drug Purchasing Policy in China: Interrupted Time-Series Analysis with Controls

Population, Clinical, and Scientific Impact of National Cancer Institute's National Clinical Trials Network Treatment Studies

Phase II Study of Rituximab Plus Three Cycles of CHOP and Involved-Field Radiotherapy for Patients With Limited-Stage Aggressive B-Cell Lymphoma: Southwest Oncology Group Study 0014

Natural History of CNS Relapse in Patients With Aggressive Non-Hodgkin's Lymphoma: A 20-Year Follow-Up Analysis of SWOG 8516—The Southwest Oncology Group

New Treatment Options Have Changed the Survival of Patients With Follicular Lymphoma

Sex, Racial, and Ethnic Representation in COVID-19 Clinical Trials: A Systematic Review and Meta-analysis

Phase II Trial of CHOP Chemotherapy Followed by Tositumomab/Iodine I-131 Tositumomab for Previously Untreated Follicular Non-Hodgkin's Lymphoma: Five-Year Follow-Up of Southwest Oncology Group Protocol S9911

Racial and Ethnic Disparity in Preference-Weighted Quality of Life: Findings from the Selenium and Vitamin E Cancer Prevention Trial

Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials

Lost in Translation: Participation in Cancer Clinical Trials for Patients With Limited English Proficiency

A comparison of nurses' and physicians' perception of cancer treatment burden based on reported adverse events

“When Offered to Participate”: A Systematic Review and Meta-Analysis of Patient Agreement to Participate in Cancer Clinical Trials

Suchergebnisse filtern